Bangladesh Journal of Pharmacology https://www.banglajol.info/index.php/BJP <p id="isPasted">The <em>Bangladesh Journal of Pharmacology</em> (Bangladesh J Pharmacol) is an open-access, video-component, and peer-reviewed biomedical science journal of the Bangladesh Pharmacological Society (BDPS).</p> <p>The journal publishes papers on the studies of plant extracts or drugs on pharmacological effects using lab animals, human cell lines, and microbes.</p> <p>The papers are Research Articles, Mini-review, Meta-analyses, Clinical Trials, Visual Experiments, and Letter to the Editor. Those who want to publish a research article must submit a video clip of one of the methodologies. Mini-reviews and Meta-analyses are usually unsolicited. A letter to the Editor is acceptable where the author(s) has data with minor dissimilarities from others' published data.</p> <p>The studies on antihypertensive drugs, anti-HIV agents, molecular docking without the data of wet lab, nanotechnology, and polyherbal products are not in the scope of this journal.</p> <p>The author will not be charged in the form of submission fee, article processing fee or publication fee. It is completely free. We do not publish any advertisement.</p> <p>The journal publishes four online issues (January, April, July, and October) per year.</p> <p><strong>Journal Metrics</strong><br />Journal metrics allow you to compare journals, regardless of their subject classification.<br />Impact Factor<sup>®</sup> as reported in the 2022 Journal Citation Reports<sup>®</sup>: <strong>1.6</strong></p> <h2><img src="https://www.banglajol.info/public/site/images/misbah/if.jpg" alt="" /></h2> <p>CiteScore (2021): <strong>2.0</strong> <a href="https://www.scopus.com/sourceid/18200156711">Current month's CiteScore Tracker</a><br />H index (2022): <strong>28 </strong>(It means 28 articles of this journal have more than 28 number of citations)</p> <p><strong>Abstracted/Indexed in</strong><br />Academic Search Complete, Bangladesh Journals Online, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Current Abstracts, <a href="http://bit.ly/2r4KLsU">Directory of Open Access Journals</a>, EMBASE/Excerpta Medica, Global Health, Google Scholar, HINARI (WHO), International Pharmaceutical Abstracts, Open J-gate, Science Citation Index Expanded, SCOPUS and Social Sciences Citation Index</p> <p><strong>Members</strong><br />Bangladesh Journal of Pharmacology is the member of <a href="https://oaspa.org/member/bangladesh-journal-of-pharmacology/">OASPA</a> (Open Access Scholarly Publishers Association), <a href="http://publicationethics.org/">COPE</a> (Committee on Publication Ethics), The International Society of Managing and Technical Editors (<a href="http://www.ismte.org/members/">ISMTE</a>) and Asian Council of Science Editors.</p> Bangladesh Pharmacological Society en-US Bangladesh Journal of Pharmacology 1991-0088 <p>Authors who publish with this journal agree to the following terms:</p> <ol> <li class="show">Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" target="_new"><span style="color: #337755;">Creative Commons Attribution License</span></a> that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.</li> <li class="show">Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.</li> <li class="show">Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See <a href="http://opcit.eprints.org/oacitation-biblio.html" target="_new"><span style="color: #337755;">The Effect of Open Access</span></a>).</li> </ol> Anti-diabetic activity of Calathea anulque https://www.banglajol.info/index.php/BJP/article/view/70296 <p>No abstract</p> Saranya Shankar Chitrashalini Srinivasan Mythili Sathiavelu Copyright (c) 2024 Saranya Shankar, Chitrashalini Srinivasan, Mythili Sathiavelu http://creativecommons.org/licenses/by/4.0 2024-03-14 2024-03-14 19 1 39 41 10.3329/bjp.v19i1.70296 Synthesis, molecular modeling, anti-cancer and COX-1/2 inhibitory activities of novel thiazolidinones containing benzothiazole core https://www.banglajol.info/index.php/BJP/article/view/70297 <p>In this study, new 1,3-thiazolidin-4-one derivatives containing arylmethylene groups in the 5-position were obtained from 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine (riluzole). Synthesized compounds were characterized by spectral data and elemental analysis. <em>In vitro</em>, cytotoxic activities of the synthesized molecules were evaluated against the human lung cancer (A549) and human prostate cancer (PC-3) cell lines. Compounds were also tested on mouse embryonic fibroblast cells (NIH/3T3) to determine selectivity. Ten target compounds <strong>3</strong>-<strong>12</strong> were also screened for their COX-1 and COX-2 inhibitory activities. Of these compounds, <strong>4</strong> showed the highest COX-2 inhibition at 10 μM. Molecular docking calculations were performed to understand the binding interactions of compounds with COX-1 and COX-2 proteins. <em>In silico</em> studies of the tested compounds represented important binding modes that may be responsible for their anti-cancer activity via selective inhibition of the COX-2 enzyme. ADMET predictions were conducted to assess the drug-like properties of the novel compounds.</p> Necla Kulabas Cansu Tamniku Guven Merve Duracık Ozlem Bingol Ozakpınar İlkay Kucukguzel Copyright (c) 2024 Necla Kulabas, Cansu Tamniku Guven, Merve Duracık, Ozlem Bingol Ozakpınar, İlkay Kucukguzel http://creativecommons.org/licenses/by/4.0 2024-03-14 2024-03-14 19 1 1 12 10.3329/bjp.v19i1.70297 Berberine triggers necroptosis of cervical H8 cells by activating receptor-interacting protein kinase 1 https://www.banglajol.info/index.php/BJP/article/view/70889 <p>This study aims to investigate the effect of berberine on necroptosis in cervical H8 cells. CCK-8 assay was used to assess cell proliferation activity. The expression levels of necroptosis key markers Receptor-interacting protein kinase 1 (RIPK1), MLKL, p-MLKL, and apoptosis-related caspase-8, caspase-3 were analyzed through qRT-PCR, western blot, and immunofluorescence. Mechanistic studies were conducted using the RIPK1 kinase inhibitor necrostatin-1 (Nec-1). The results showed that berberine could inhibit H8 cell proliferation in a time- and dose-dependent manner (p&lt;0.05). It increased the expression of RIPK1 and MLKL (p&lt;0.05), while inhibiting the expression of caspase-8 and caspase-3 (p&lt;0.05). Nec-1 inhibitor decreased the expression of RIPK1 and MLKL after the intervention of berberine (p&lt;0.05). Therefore, berberine induces cervical H8 cell death through the activation of RIPK1-mediated necroptosis.</p> Mengting Wang Huixian Chen Qian Wu Yan Huang Yuzhen Zhou Copyright (c) 2024 Mengting Wang, Huixian Chen, Qian Wu, Yan Huang, Yuzhen Zhou http://creativecommons.org/licenses/by/4.0 2024-03-14 2024-03-14 19 1 13 22 10.3329/bjp.v19i1.70889 In vitro anti-cancer activity of Epipremnum aureum https://www.banglajol.info/index.php/BJP/article/view/71024 <p>In the present study, <em>in vitro </em>anti-cancer activity of aerial parts of <em>Epipremnum aureum </em>extracts was performed using the MCF-7 breast cancer cell line. Soxhlet method was used with different solvents for extract preparation. The amount of apoptosis in MCF-7 cells was assessed using flow cytometry for each of the extracts. The chloroform and ethanol extracts had a considerable cytotoxic effect with IC<sub>50</sub> values of 32.9 and 45.8 μg/mL respectively, while the conventional medication 5-fluorouracil produced an IC<sub>50</sub> value of 19.2 μg/mL. The microscopic examination of the chloroform and ethanol extracts of <em>E. aureum</em> revealed the presence of apoptotic bodies, nuclear fragmentation, and tiny nuclei with strong chromatin condensation. These results suggest that chloroform extract of <em>E. aureum</em> is more effective against breast cancer. </p> Sudhir S. Patil Kiran A. Wadkar Copyright (c) 2024 Sudhir S. Patil, Kiran A. Wadkar http://creativecommons.org/licenses/by/4.0 2024-03-14 2024-03-14 19 1 23 28 10.3329/bjp.v19i1.71024 Nigella sativa plant extract inhibits the proliferation of MDA-MB-231 breast cancer cells via apoptosis and cell cycle arrest https://www.banglajol.info/index.php/BJP/article/view/71069 <p>The study was designed to evaluate the antiproliferative effects of <em>Nigella sativa</em> plant ethanol extract against MDA-MB-231 triple-negative breast cancer cells. DAPI and annexin V/propidium iodide staining assays were used to examine apoptosis. Results showed that <em>N. sativa</em> extract significantly (p&lt;0.05) impeded the growth of MDA-MB-231 cells, with IC<sub>50</sub> of 12.5 μg/mL. The colony-forming potential of MDA-MB-231 was significantly (p&lt;0.05) decreased by the <em>N. sativa</em> extract-induced apoptosis. Increased expression of Bax, caspase-3, cleaved caspase-3, and cleaved PARP was also observed in the extract-treated MDA-MB-231 cells. Moreover, flow cytometric analysis showed that <em>N. sativa </em>extract triggered G<sub>0</sub>/G<sub>1</sub> phase arrest in MDA-MB-231 cells. Collectively, <em>N. sativa</em> extract exhibits potent antiproliferative activity against triple-negative breast cancer cells and may be used as a source of anti-cancer agents.</p> Jie Ma Cong Peng Copyright (c) 2024 Jie Ma, Cong Peng http://creativecommons.org/licenses/by/4.0 2024-03-14 2024-03-14 19 1 29 38 10.3329/bjp.v19i1.71069